FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ingrid Philippens

Research Profile

Living Beings

Chemicals & Drugs

Activities & Behaviors

Procedures

Electroencephalography

Disorders

Physiology

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Peternella S Verhave; Marjan J Jongsma; August B Smit; Roland M Van Den Berg; Raymond A P Vanwersch; Ingrid H C H M Philippens
Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.
Herman P M Van Helden; Marloes J A Joosen; Ingrid H C H M Philippens
Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.
Ingrid H C H M Philippens; Bert A 't Hart; German Torres
The MPTP marmoset model of parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ingrid Philippens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Peternella S Verhave; Marjan J Jongsma; August B Smit; Roland M Van Den Berg; Raymond A P Vanwersch; Ingrid H C H M Philippens
Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.
Neuropharmacology 2012;62(4):1700-7.
2011: Herman P M Van Helden; Marloes J A Joosen; Ingrid H C H M Philippens
Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.
Toxicology letters 2011;206(1):35-40.
2010: Ingrid H C H M Philippens; Bert A 't Hart; German Torres
The MPTP marmoset model of parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases.
Drug discovery today 2010;15(23-24):985-90.
2010: Martijn J H Agterberg; Marloes van den Broek; Ingrid H C H M Philippens
A less stressful animal model: a conditioned avoidance behaviour task for guineapigs.
Laboratory animals 2010;44(3):206-10.
2010: Ingrid H C H M Philippens; Raymond A P Vanwersch
Neurofeedback training on sensorimotor rhythm in marmoset monkeys.
Neuroreport 2010;21(5):328-32.
2009: Peternella S Verhave; Raymond A P Vanwersch; Herman P M Van Helden; August B Smit; Ingrid H C H M Philippens
Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease.
Behavioural brain research 2009;200(1):214-9.
2008: Sanneke A M van Vliet; Raymond A P Vanwersch; Marjan J Jongsma; Berend Olivier; Ingrid H C H M Philippens
Therapeutic effects of Delta9-THC and modafinil in a marmoset Parkinson model.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(5):383-9.
2008: Sanneke A M van Vliet; Marjan J Jongsma; Raymond A P Vanwersch; Berend Olivier; Ingrid H C H M Philippens
Efficacy of caffeine and modafinil in counteracting sleep deprivation in the marmoset monkey.
Psychopharmacology 2008;197(1):59-66.
2008: S A M van Vliet; S A M van Vlieta; E L A Blezer; M J Jongsma; Raymond A P Vanwersch; Berend Olivier; Ingrid H C H M Philippens
Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
Brain research 2008;1189():219-28.
2006: Sanneke A M van Vliet; Raymond A P Vanwersch; Marjan J Jongsma; Jan van der Gugten; Berend Olivier; Ingrid H C H M Philippens
Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects.
Behavioural pharmacology 2006;17(5-6):453-62.
2006: Sanneke A M van Vliet; Marjan J Jongsma; Raymond A P Vanwersch; Berend Olivier; Ingrid H C H M Philippens
Behavioral effects of modafinil in marmoset monkeys.
Psychopharmacology 2006;185(4):433-40.
2005: Ingrid H C H M Philippens; Marloes J A Joosen; Raymond A P Vanwersch
Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs.
Pharmacology, biochemistry, and behavior 2005;82(1):125-32.
2004: Herman P M Van Helden; Raymond A P Vanwersch; Willem C Kuijpers; Henk C Trap; Ingrid H C H M Philippens; Hendrik P Benschop
Low levels of sarin affect the EEG in marmoset monkeys: a pilot study.
Journal of applied toxicology : JAT 2004;24(6):475-83.
2001: DM de Groot; E P Bierman; Pieter L B Bruijnzeel; Pierre Carpentier; B M Kulig; Guy Lallement; BP Melchers; Ingrid H C H M Philippens; A H van Huygevoort
Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour.
Journal of applied toxicology : JAT 2001;21 Suppl 1():S57-65.
2000: Ingrid H C H M Philippens; BP Melchers; T A Roeling; Pieter L B Bruijnzeel
Behavioral test systems in marmoset monkeys.
Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc 2000;32(1):173-9.
2000: Ingrid H C H M Philippens; Raymond A P Vanwersch; Bas Groen; Berend Olivier; Pieter L B Bruijnzeel; BP Melchers
Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation.
Toxicological sciences : an official journal of the Society of Toxicology 2000;53(1):84-91.
2000: Ingrid H C H M Philippens; BP Melchers; Berend Olivier; Pieter L B Bruijnzeel
Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs.
Pharmacology, biochemistry, and behavior 2000;65(1):175-82.
1998: Ingrid H C H M Philippens; R W Busker; O L Wolthuis; Berend Olivier; Pieter L B Bruijnzeel; BP Melchers
Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects.
Pharmacology, biochemistry, and behavior 1998;59(4):1061-7.
1997: Ingrid H C H M Philippens; Berend Olivier; BP Melchers
Effects of physostigmine on the startle in guinea pigs: two mechanisms involved.
Pharmacology, biochemistry, and behavior 1997;58(4):909-13.
1996: R W Busker; J J Zijlstra; Ingrid H C H M Philippens; B Groen; BP Melchers
Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys.
Toxicology 1996;112(3):183-94.
1996: Ingrid H C H M Philippens; O L Wolthuis; R W Busker; J P Langenberg; BP Melchers
Side effects of physostigmine as a pretreatment in guinea pigs.
Pharmacology, biochemistry, and behavior 1996;55(1):99-105.
1994: BP Melchers; Ingrid H C H M Philippens; O L Wolthuis
Efficacy of HI-6 and HLö-7 in preventing incapacitation following nerve agent poisoning.
Pharmacology, biochemistry, and behavior 1994;49(4):781-8.
1994: O L Wolthuis; B Groen; Ingrid H C H M Philippens
A simple automated test to measure exploratory and motor activity of marmosets.
Pharmacology, biochemistry, and behavior 1994;47(4):879-81.
1992: Ingrid H C H M Philippens; BP Melchers; D M de Groot; O L Wolthuis
Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats.
Pharmacology, biochemistry, and behavior 1992;42(4):711-9.
1992: Ingrid H C H M Philippens; BP Melchers; O L Wolthuis
Active avoidance behavior in guinea pigs: effects of physostigmine and scopolamine.
Pharmacology, biochemistry, and behavior 1992;42(2):285-9.
1991: O L Wolthuis; Ingrid H C H M Philippens; R A Vanwersch
On the development of behavioral tolerance to organophosphates. IV: EEGand visual evoked responses.
Pharmacology, biochemistry, and behavior 1991;39(4):851-8.
1990: O L Wolthuis; Ingrid H C H M Philippens; R Vanwersch
On the development of behavioral tolerance to organophosphates. III: Behavioral aspects.
Pharmacology, biochemistry, and behavior 1990;35(3):561-5.
1989: O L Wolthuis; Ingrid H C H M Philippens; R A Vanwersch
Side effects of therapeutic drugs against organophosphate poisoning.
Neurotoxicology and teratology 1989;11(3):221-5.